Do you have any explanation for why liraglutide was associated a lower risk of hypoglycemia than in the control arm of the LEADER trial?

Do you have any explanation for why liraglutide was associated a lower risk of hypoglycemia than in the control arm of the LEADER trial?

Do you have any explanation for why liraglutide was associated a lower risk of hypoglycemia than in the control arm of the LEADER trial?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Steve Bain, MD

Steve Bain, MD

Professor of Medicine (Diabetes)
College of Medicine
Swansea University
Swansea, UK